Arcellx, Inc.
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical tr…
Biotechnology
US, Gaithersburg [HQ]
Balance Sheet
5 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Assets | 43.00 | 57.00 | 128.00 | 313.00 | 825.00 | |
|
Current
|
38.00 | 49.00 | 112.00 | 266.00 | 716.00 | |
| Cash And Equivalents | 34.00 | 46.00 | 104.00 | 64.00 | 394.00 | |
| Assets | 43.00 | 57.00 | 128.00 | 313.00 | 825.00 | |
| Accounts Receivables (AR) | - - | - - | - - | - - | - - | |
| Inventory | - - | - - | - - | - - | - - | |
| Short Term Investments | - - | - - | 73.00 | 190.00 | 307.00 | |
| Other Current Assets | - - | 1.00 | 2.00 | 12.00 | 14.00 | |
|
Non Current
|
5.00 | 8.00 | 15.00 | 46.00 | 96.00 | |
| Property, Plant, Equipment (Net) | 4.00 | 4.00 | 10.00 | 39.00 | 69.00 | |
|
Intangible Assets
|
- - | - - | - - | - - | - - | |
| Goodwill | - - | - - | - - | - - | - - | |
| Long Term Investments | - - | - - | - - | 2.00 | 27.00 | |
| Other Non Current Assets | 1.00 | 3.00 | 5.00 | 4.00 | -96.00 | |
| Liabilities | 76.00 | 121.00 | 250.00 | 108.00 | 339.00 | |
|
Current
|
3.00 | 5.00 | 14.00 | 56.00 | 118.00 | |
| Accounts Payable | - - | -1.00 | - - | 7.00 | -6.00 | |
| Short Term Debt | - - | - - | - - | 35.00 | 46.00 | |
| Deferred Revenue | - - | - - | - - | - - | 50.00 | |
| Tax Payable | - - | - - | - - | - - | - - | |
| Other Current Liabilities | 1.00 | 4.00 | 13.00 | 11.00 | 18.00 | |
|
Non Current
|
73.00 | 116.00 | 235.00 | 52.00 | 221.00 | |
| Long Term Debt | - - | - - | - - | 52.00 | 50.00 | |
| Leasing Obligations | - - | - - | - - | 88.00 | 50.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | -170.00 | |
| Other Non Current Liabilities | 73.00 | 116.00 | 235.00 | - - | 170.00 | |
| Equity | -32.00 | -63.00 | -121.00 | 204.00 | 485.00 | |
| Stockholders' Equity | -32.00 | -63.00 | -121.00 | 204.00 | 485.00 | |
| Retained Earnings | -33.00 | -65.00 | -130.00 | -318.00 | -389.00 | |
| Common Stock | - - | - - | - - | - - | - - | |
| Preferred Stock | 71.00 | 114.00 | 28.00 | - - | - - | |
| Profit | -17.00 | -32.00 | -63.00 | -186.00 | -70.00 | |
| Dividends | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | - - | 1.00 | -20.00 | 523.00 | 874.00 | |
| Loss Other Compr. Income | -71.00 | -114.00 | - - | - - | - - |